Your browser doesn't support javascript.
loading
Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA.
Holland, Christopher J; Crean, Rory M; Pentier, Johanne M; de Wet, Ben; Lloyd, Angharad; Srikannathasan, Velupillai; Lissin, Nikolai; Lloyd, Katy A; Blicher, Thomas H; Conroy, Paul J; Hock, Miriam; Pengelly, Robert J; Spinner, Thomas E; Cameron, Brian; Potter, Elizabeth A; Jeyanthan, Anitha; Molloy, Peter E; Sami, Malkit; Aleksic, Milos; Liddy, Nathaniel; Robinson, Ross A; Harper, Stephen; Lepore, Marco; Pudney, Chris R; van der Kamp, Marc W; Rizkallah, Pierre J; Jakobsen, Bent K; Vuidepot, Annelise; Cole, David K.
Afiliação
  • Holland CJ; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Crean RM; Department of Biology and Biochemistry and.
  • Pentier JM; Doctoral Training Centre in Sustainable Chemical Technologies, University of Bath, Bath, United Kingdom.
  • de Wet B; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Lloyd A; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Srikannathasan V; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Lissin N; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Lloyd KA; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Blicher TH; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Conroy PJ; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Hock M; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Pengelly RJ; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Spinner TE; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Cameron B; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Potter EA; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Jeyanthan A; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Molloy PE; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Sami M; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Aleksic M; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Liddy N; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Robinson RA; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Harper S; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Lepore M; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Pudney CR; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • van der Kamp MW; Department of Biology and Biochemistry and.
  • Rizkallah PJ; School of Biochemistry, University of Bristol, Bristol, United Kingdom.
  • Jakobsen BK; Cardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.
  • Vuidepot A; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
  • Cole DK; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.
J Clin Invest ; 130(5): 2673-2688, 2020 05 01.
Article em En | MEDLINE | ID: mdl-32310221

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Receptores de Antígenos de Linfócitos T / Antígenos HLA Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Receptores de Antígenos de Linfócitos T / Antígenos HLA Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
...